As cancer has become a major, serious and a complex problem, it is very essential to put a huge effort to understand and control it, that is possible with the help of original and innovative research findings that helps to disseminate knowledge regarding the etiology of cancer and also improvements can be made in its treatment that facilitates the survival of patients. EC Cancer is a platform to bring into light the major advances in cancer research and oncology.

Molecular and cellular mechanisms of cancer, Mechanisms for the sensitivity and the resistance to cancer therapies and development of better cancer therapies, Cancer genetics, Cancer cytology, Cancer pathology, Gynaecologic cancer, Ovarian cancer, Clinical aspects of cancer, Liver cancer, Lung cancer, Cancer endocrinology, Genitourinary cancer, Colorectal cancer, Bone cancer, Prostate cancer, Benign tumours, Cancer chemotherapy, Pediatric oncology, Cancer prevention, Recent developments in tumor therapy, Radiation oncology, Apoptosis, Oncogenes, Angiogenesis, Metastasis, Cancer image and interventional diagnosis and therapy, Tumor markers, Chemotherapy, Radiotherapy and biotherapy, Veterinary and Comparative oncology, Clinical trials in oncology, Cancer nanotechnology, Carcinoma, Sarcoma, Myeloma, Leukemia, Lymphoma, Osteosarcoma or Osteogenic sarcoma, Chondrosarcoma, Leiomyosarcoma, Rhabdomyosarcoma, Mesothelial sarcoma or mesothelioma, Fibrosarcoma, Angiosarcoma or Haemangioendothelioma, Liposarcoma, Glioma or Astrocytoma, Myxosarcoma, Mesenchymous or Mixed mesodermal tumor. All the topics relevant to cancer are accepted by EC Cancer that aims to provide information on original cancer research.

The journal delightfully welcomes original articles on all the relevant topics of cancer at  editor@ecronicon.uk